Survival Trends in Infants Undergoing Allogeneic Hematopoietic Cell Transplant
Suhag Parikh(Emory University), Alison W. Loren(University of Pennsylvania), Kasiani C. Myers(Immune Deficiency Foundation), Seth J. Rotz(Cleveland Clinic), Vaibhav Agrawal(City Of Hope National Medical Center), Edward A. Copelan(Levine Cancer Institute), Gerhard Hildebrandt(University of Missouri Health System), Haydar Frangoul(Children’s Hospital at TriStar Centennial), Kirsten M. Williams(National Institutes of Health), Peiman Hematti(UW Health University Hospital), Hillard M. Lazarus(University Hospitals of Cleveland), César O. Freytes(CHRISTUS Transplant Institute), Shahrukh K. Hashmi(Mayo Clinic), Christopher C. Dvorak(University of California, San Francisco), Allistair Abraham(Children's National), Prakash Satwani(Pediatrics and Genetics), Amy K. Keating(Boston Children's Hospital), Baldeep Wirk(Boston University), Usama Gergis(Thomas Jefferson University Hospital), Hisham Abdel‐Azim(University of Southern California), Shahinaz M. Gadalla(Division of Cancer Epidemiology and Genetics), Biju George(Westmead Hospital), Richard F. Olsson(AstraZeneca (Netherlands)), Natasha Sahr(Medical College of Wisconsin), Jeffery J. Auletta(Nationwide Children's Hospital), Marcelo C. Pasquini(Cleveland Clinic), Robert Peter Gale(Imperial College London), Bipin N. Savani(Vanderbilt University Medical Center), Miguel-Angel Diaz(Hospital Infantil Universitario Niño Jesús), Timothy Prestidge(Starship Children's Health), Kwang Woo Ahn(Medical College of Wisconsin), Caitrin Fretham(National Marrow Donor Program), Evan Shereck(Oregon Health & Science University)
Cited by 22
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
|New England Journal of Medicine|2020|1.8k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k